Infectious Diseases (except HIV/AIDS)

Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays

1. Erik Jue
2. Rustem F. Ismagilov

Global academic response to COVID-19: Cross-sectional study

1. Jack A Helliwell
2. William S Bolton
3. Joshua R Burke
4. Jim P Tiernan
5. David G Jayne
6. Stephen J Chapman

Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics

1. Christoph B. Messner
2. Vadim Demichev
3. Daniel Wendisch
4. Laura Michalick
5. Matthew White
6. Anja Freiwald
7. Kathrin Textoris-Taube
8. Spyros I. Vernardis
9. Anna-Sophia Egger
10. Marco Kreidl
11. Daniela Ludwig
12. Christiane Kilian
13. Federica Agostini
14. Aleksej Zelezniak
15. Charlotte Thibeault
16. Moritz Pfeiffer
17. Stefan Hippenstiel
18. Andreas Hocke
19. Christof von Kalle
20. Archie Campbell
21. Caroline Hayward
22. David J. Porteous
23. Riccardo E. Marioni
24. Claudia Langenberg
25. Kathryn S. Lilley
26. Wolfgang M. Kuebler
27. Michael Mülleder
28. Christian Drosten
29. Martin Witzenrath
30. Florian Kurth
31. Leif Erik Sander
32. Markus Ralser

Pre-test probability for SARS-Cov-2-related Infection Score: the PARIS score

Predictive value of sudden olfactory loss in the diagnosis of COVID-19

1. Antje Haehner
2. Julia Draf
3. Sarah Dräger
4. Katja de With
5. Thomas Hummel

Direct observation of repeated infections with endemic coronaviruses

1. Marta Galanti
2. Jeffrey Shaman

Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)

1. Katja Radon
2. Elmar Saathoff
3. Michael Pritsch
4. Jessica Michelle Guggenbühl Noller
5. Inge Kroidl
6. Laura Olbrich
7. Verena Thiel
8. Max Diefenbach
9. Friedrich Riess
10. Felix Forster
11. Fabian Theis
12. Andreas Wieser
13. Michael Hoelscher
14. the KoCo19 collaboration group#

Beyond the Spike: identification of viral targets of the antibody response to SARS-CoV-2 in COVID-19 patients

1. Asmaa Hachim
2. Niloufar Kavian
3. Carolyn A Cohen
4. Alex WH Chin
5. Daniel KW Chu
6. Chris Ka Pun Mok
7. Owen TY Tsang
8. Yiu Cheong Yeung
9. Ranawaka APM Perera
10. Leo LM Poon
11. Malik JS Peiris
12. Sophie A Valkenburg

Early viral clearance and antibody kinetics of COVID-19 among asymptomatic carriers

1. Tongyang Xiao
2. Yanrong Wang
3. Jing Yuan
4. Haocheng Ye
5. Lanlan Wei
6. Xuejiao Liao
7. Haiyan Wang
8. Shen Qian
9. Zhaoqin Wang
10. Lei Liu
11. Zheng Zhang

Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients

1. Maia Norman
2. Tal Gilboa
3. Alana F. Ogata
4. Adam M. Maley
5. Limor Cohen
6. Yongfei Cai
7. Jun Zhang
8. Jared E. Feldman
9. Blake M. Hauser
10. Timothy M. Caradonna
11. Bing Chen
12. Aaron G. Schmidt
13. Galit Alter
14. Richelle C. Charles
15. Edward T. Ryan
16. David R. Walt